Sonoma pharmaceuticals announces appointment of hye jin chung, m.d. to scientific advisory board

Boulder, co / accesswire / august 3, 2023 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced the appointment of dr. hye jin chung md, mmsc, assistant professor of dermatology at harvard medical school in boston and practicing dermatologist at beth israel deaconess medical center, to the company's scientific advisory board. sonoma's scientific advisory board will be comprised of a small group of physicians with expertise in the areas of dermatology, skin care, wound care, eye, oral and nasal care, and animal health.
SNOA Ratings Summary
SNOA Quant Ranking